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Abstract
The UK Adult ADHD Network (UKAAN) was founded by a group of mental health specialists who have experience
delivering clinical services for adults with Attention Deficit Hyperactivity Disorder (ADHD) within the National
Health Service (NHS). UKAAN aims to support mental health professionals in the development of services for adults
with ADHD by the promotion of assessment and treatment protocols. One method of achieving these aims has
been to sponsor conferences and workshops on adult ADHD.
This consensus statement is the result of a Forensic Meeting held in November 2009, attended by senior
representatives of the Department of Health (DoH), Forensic Mental Health, Prison, Probation, Courts and Metropolitan
Police services. The objectives of the meeting were to discuss ways of raising awareness about adult ADHD, and its
recognition, assessment, treatment and management within these respective services. Whilst the document draws on
the UK experience, with some adaptations it can be used as a template for similar local actions in other countries.
It was concluded that bringing together experts in adult ADHD and the Criminal Justice System (CJS) will be vital to
raising awareness of the needs of ADHD offenders at every stage of the offender pathway. Joint working and
commissioning within the CJS is needed to improve awareness and understanding of ADHD offenders to ensure that
individuals are directed to appropriate care and rehabilitation. General Practitioners (GPs), whilst ideally placed for early
intervention, should not be relied upon to provide this service as vulnerable offenders often have difficulty accessing
primary care services. Moreover once this hurdle has been overcome and ADHD in offenders has been identified, a
second challenge will be to provide treatment and ensure continuity of care. Future research must focus on proof of
principle studies to demonstrate that identification and treatment confers health gain, safeguards individual’s rights,
improves engagement in offender rehabilitation programmes, reduces institutional behavioural disturbance and,
ultimately, leads to crime reduction. In time this will provide better justice for both offenders and society.
Introduction
UKAAN was established in 2009 in response to UK
guidelines issued by the National Institute for Clinical
Excellence (NICE) in 2009 [1] and the British Associa-
tion of Psychopharmacology [2] which for the first time
gave evidence based guidance on the need to diagnose
and treat ADHD in both adults and children.
ADHD is a clinical syndrome defined in the Diagnos-
tic and Statistical Manual - Fourth Edition (DSM-IV)
and International Statistical Classification of Diseases -
Tenth Revision (ICD-10) by high levels of hyperactive,
impulsive and inattentive behaviours beginning in early
childhood. The disorder is common in the population
with prevalence estimates in the UK of around 3-4% [3].
Follow-up studies of ADHD in children find that the
disorder frequently persists with around 15% retaining a
full diagnosis by 25 years, and a further 50% retaining
some symptoms leading to continued impairments in
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daily life [4]. A recent review and meta-analysis esti-
mated the world prevalence in adults to average 2.5% or
higher [5]; with around 1% expected to fall in the most
severe group requiring immediate treatment. In the UK,
the rate of adult ADHD has been estimated at 1% [3].
While ADHD-like symptoms are found in many peo-
ple some of the time, in people with ADHD they are
severe, persistent over time and lead to clinically signifi-
cant impairments. Impairments can impact on an indivi-
dual in several ways including: low self-esteem,
educational and occupational problems, problems in
social interactions and relationships, antisocial beha-
viour, the development of comorbid psychiatric symp-
toms, syndromes and disorders, and the capacity to
cope with police interviews and court procedures [1].
Comorbidities in ADHD are common and include other
neurodevelopmental disorders such as autism spectrum
disorders and dyslexia, drug and alcohol abuse disorders,
personality disorder, or other common mental health
problems such as anxiety and depression [1].
ADHD in Forensic Settings
Research suggests there is a disproportionately high con-
centration of ADHD individuals involved with the CJS,
and for these individuals criminal justice procedures
often interface with a complex web of behaviour, sub-
stance use and mental health issues. International studies
from the USA [6], Canada [7], Sweden [8,9], Germany
[10-12], Finland [13] and Norway [14] report that up to
two-thirds of young offenders and half of the adult prison
population screen positively for childhood ADHD, and
many continue to be symptomatic with rates reported at
14% in adult male offenders [15] and 10% in adult female
offenders [10]. In young offenders rates are around 45%
[12,16]. A UK study of personality disorder wards in For-
ensic Mental Health Services found similar screening
rates (33%), with a sizeable number of individuals in par-
tial remission of symptoms [17].
UK prison studies have indicated a rate of 43% in
14-year-old youths [16] and 24% in male adults screening
positive for a childhood history, 14% of whom had per-
sisting symptoms [15]. Those with persisting symptoms
accounted for eight times more aggressive incidents than
other prisoners and six times more than prisoners with
Antisocial Personality Disorder. They had a significantly
younger onset of offending by around 2.5 years (16 vs.
19.5 years); and they had a significantly higher rate of
recidivism [18]. ADHD was the most important predictor
of violent offending, even above substance misuse.
Thus the rate of ADHD in the CJS far exceeds that in
the general population, and offender behaviour, both
within and outside of prison settings, is something that
society cannot afford to ignore. The higher rate of
ADHD individuals involved in the CJS however is not
paralleled by the knowledge, skills and training of practi-
tioners in the disorder and who are involved in their
care. NICE Guidelines for ADHD [1] were comprehen-
sive in their recommendations for service delivery,
emphasising the need for integrated services reflecting
developmental needs across the lifespan, including for-
ensic services. Establishing who, out of the ‘mixed bag’
of individuals within forensic services has a diagnosis of
ADHD and will benefit from ADHD treatment as a
first-line primary intervention (rather than treatment
targeting substance use or other mental health pro-
blems) is an important question.
Offender Health
In the past few years commissioning responsibilities for
prison healthcare have transferred from the prison ser-
vice to the NHS in order to:
1) Increase investment in prisoner health.
2) Raise services to NHS standard.
3) Provide continuity for those in prison who later
return to communities.
A central tenet is that prisoners should be considered
as part of the community and treated within mainstream
services with access to the same standards of health and
social care as the rest of the population. Nevertheless, it
is recognised that there exists a sub-group of individuals
who have particular difficulty navigating the system, per-
haps due to poor educational ability, disturbed mental
state, and/or substance misuse. By supporting these
individuals in their care and through the provision of
integrated services, the justice they receive will also be
supported.
Offender Health now exists as a partnership between
the Ministry of Justice and the DoH and, to date, the
focus has been to:
1) Develop mental health transfer protocols to facili-
tate the transfer of those with severe mental illness to
mental health settings.
2) Introduce an Integrated Treatment System, which
draws together clinical interventions for prisoners (e.g.
methadone maintenance and psychosocial interventions).
In response to the recommendations of the Bradley
Report [19], a national Health and Criminal Justice Pro-
gramme Board has been set up, bringing together gov-
ernment departments for health, social care and
criminal justice. The Board have devised a National
Delivery Plan [20] committed to improving the manage-
ment of offenders with mental health problems, learning
disability and personality disorder, which provides an
opportunity to move ADHD up the care agenda. Its key
objectives are to:
1) Improve system effectiveness and efficiency.
2) Work in partnership.
3) Improve capacity and capability.
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4) Develop an equity of access to existing general ser-
vices and/or specialised services for ADHD.
5) Improve pathways and continuity of care.
The Health and Criminal Justice Programme Board is
supported by a National Advisory Group, which pro-
vides independent, evidence-based advice to the Board
on the developing agenda, and highlights examples of
good practice and the commissioning of in-depth stu-
dies in areas of interest. Thus this National Advisory
Group will provide a mechanism for UKAAN to raise
the profile of ADHD offenders at the highest level.
However, the volume and scale of activity within the
CJS will influence what can realistically be achieved in
terms of ADHD screening, assessment and treatment,
and new developments must be integrated with existing
protocols and run in a system at high capacity. Health
inequality is common in the prison population for many
reasons (e.g. personal and socio-economic, community,
lack of continuity, failure to access general services), and
the DoH has expressed commitment to raising stan-
dards for the benefit of prisoners and with a view to
improving longer term outcomes such as a reduction in
reoffending and positive integration into the community.
However there is no ‘quick fix’ as most prison inmates
are young men with complex healthcare needs, includ-
ing alcohol and substance misuse problems and psycho-
logical problems. On the other hand health assessments
and interventions often have to be rapidly implemented
as approximately half of prison inmates stay in prison
for an average of six months or less. Nevertheless there
is room for innovation - screening at prison reception
has improved and non-health staff are now involved in a
preliminary screening process, which triggers a more
comprehensive assessment, if required, conducted by
health staff. The Integrated Treatment System is the
appropriate pathway for introducing ADHD assessment
and management as this will include after-care arrange-
ments, e.g. for treatment post-discharge.
The Bradley Report
The Bradley Report [19] was commissioned in Decem-
ber 2007 to examine the extent to which offenders with
mental health problems or learning disabilities could, in
appropriate cases, be diverted from prison to other ser-
vices and the barriers to such diversion; and to make
recommendations to government, in particular on the
organisation of effective court liaison and diversion
arrangements and the services needed to support them.
The focus was expanded to include a more comprehen-
sive consideration of the ‘offender pathway’ and asso-
ciated mental health services, and in compiling the
report Lord Keith Bradley visited a wide range of facil-
ities throughout the country. Nationally, Lord Bradley’s
Report makes over 80 recommendations to Government
which would ensure public protection, appropriate jus-
tice and that people with mental health problems or
learning difficulties are identified and treated as they
pass through the CJS and re-enter society. The Bradley
Report predominantly focused on adults with mental
health problems and learning disability, and ADHD does
not fit well within either category. Nevertheless, the
Bradley Report has some translational value for youths
and adults with ADHD. Thus these proceedings high-
light key recommendations of the Bradley Report where
deemed appropriate. Table 1 presents key recommenda-
tions across criminal justice services and Table 2 pre-
sents key recommendations for youth services from the
Bradley Report Executive Summary [19].
Identification and Screening Procedures
Currently the National Criminal Justice Board meets
regionally and nationally, with representation by the
courts, police, probation and prison services. Screening
systems already exist in CJS services and we need to
identify ways of building on these systems to incorpo-
rate screening for ADHD. Making representations to the
National Criminal Justice Board might be one way to
move forward. In developing an effective and efficient
screening protocol for ADHD within various CJS set-
tings and in developing appropriate care pathways, it
will be important to determine the level of awareness
that exists in services, what screens are currently used,
and what a positive screen triggers in terms of indivi-
duals progressing through CJS procedures and services.
Police Services
Table 3 presents recommendations for policing and
community care from the Bradley Report Executive
Summary [19]. The culture of present day policing is
heading towards a crime reduction strategy, and new
procedures and performance indicators have been intro-
duced in order to maximise crime reduction and
improve cost-efficiency. However, busy police custody
suites manage a high turnover of detainees (more than
half of whom are intoxicated), which complicates any
systematic screening. The Police and Criminal Evidence
Act led to improved recording of information and data
Table 1 Key recommendations made in Bradley Report
(2009) across criminal justice services
- Improve awareness, identification, assessment and training in mental
health needs.
- Ensure qualified individuals exist within services to make appropriate
referrals.
- Review the potential for early examination and intervention in
childhood.
- Form closer links between services (e.g. joint-training packages,
information sharing).
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are now recorded about an individual’s behaviour, physi-
cal and mental health. However mental health needs are
not perceived to be a priority. Thus internal cultural
changes will be required to raise awareness and recogni-
tion of ADHD. Training opportunities are available for
police officers, in particular for custody officers who
complete initial and refresher training in line with new
legislation or developments.
The Criminal Intelligence System database includes
mental health data and, once improved, screens will be
standardised and introduced nationally providing an effi-
cient and cost-effective way of sharing data and alerting
staff to particular needs (in line with confidentiality leg-
islation). Currently a Risk Assessment screen is given to
every person received into custody and this includes
questions about current mental state (e.g. risks posed by
depression, suicidal ideation and self-harm). This trig-
gers a follow-up primary care screen within 48 hours (to
which ADHD items could be added) and/or contact
with a forensic medical examiner to ensure that the
individual is fit to be detained and interviewed. It also
identifies individuals who require regular observations
(e.g. to prevent suicide). For those fit for interview,
other provisions can be made. In the UK for example, if
a detainee is suspected of having a mental health need
they must be supported by an appropriate adult (AA)
during interview. The AA can give advice to all parties,
furthers communication and ensures that the interview
is fair, however even when ADHD is recognised, detai-
nees will not necessarily be entitled to an AA unless
triggered by some additional problem (e.g. learning dis-
ability). It is important to note that for many young
offenders the AA will be a parent and, given the heredi-
tary nature of ADHD, this in itself may have implica-
tions for the custody process. Furthermore, some
countries do not have the AA system in place, in which
case the vulnerability of detainees with ADHD (recog-
nised or unrecognised) is more serious as they get no
additional support. It is recognised that the introduction
of improved screening may result in more detainees
requiring an AA, and a revised AA scheme is due to be
introduced, providing opportunities to introduce ADHD
training and/or psychoeducational materials on ADHD
recognition, treatment and management.
In completing any screen, detainees may be resistant
to engage with officers who have arrested or detained
them, thus it is important that screens are completed
sensitively to avoid disclosure being limited if detainees
perceive stigma associated with their endorsing mental
health problems. Language barriers are routinely over-
come by the use of interpreters who can attend the
police station within two hours. Cultural barriers also
need consideration, as does the perception that if a
mental health need is disclosed or suspected, the crim-
inal justice process will be lengthened.
Courts Services
The need for close working relationships between health
professionals and the courts has been documented in
The Bradley report [19] (see Table 4) and by the DoH
[21,22] and a merging of services is clearly taking place
[23]. Her Majesty’s Courts Service has responded to the
Bradley recommendations by considering the implemen-
tation of Criminal Justice Mental Health Teams, and the
first specific courts for offenders with mental health pro-
blems or learning disabilities have been piloted in
Brighton and at Stratford magistrates’ courts. Neverthe-
less, it is recognised that provision of diversion schemes
varies throughout the country with some areas relying on
the voluntary sector and some having no support at all
[24], while others have designated workers providing for-
ensic support to youths and adults. Both the Magistrates
and Crown Court Judiciary receive training provided by
Table 2 Key youth recommendations from the Bradley
Report Executive Summary (2009)
- Youth Offending Teams must include a suitably qualified mental
health worker who is responsible for making appropriate referrals to
services.
- The Government should undertake a review to examine the potential
for early intervention and diversion for children and young people with
mental health problems or learning disabilities who have offended or
are at risk of offending, with the aim of bringing forward appropriate
recommendations which are consistent with this wider review.
Table 3 Recommendations for policing and community
care from the Bradley Report Executive Summary (2009)
- Local Safer Neighbourhood Teams should play a key role in
identifying and supporting people in the community with mental
health problems or learning disabilities who may be involved in low-
level offending or anti-social behaviour by establishing local contacts
and partnerships and developing referral pathways.
- Community support officers and police officers should link with local
mental health services to develop joint training packages for mental
health awareness and learning disability issues.
- A review of the role of Appropriate Adults in police stations should be
undertaken and aim to improve the consistency, availability and
expertise of this role.
- Appropriate Adults should receive training to ensure the most
effective support for individuals with mental health problems or
learning disabilities.
- Mental health awareness and learning disabilities should be a key
component in the police training programme.
- All police custody suites should have access to liaison and diversion
services. These services would include improved screening and
identification of individuals with mental health problems or learning
disabilities, providing information to police and prosecutors to facilitate
the earliest possible diversion of offenders with mental disorders from
the criminal justice system, and signposting to local health and social
care services as appropriate.
- Liaison and diversion services should also provide information and
advice services to all relevant staff including solicitors and Appropriate
Adults.
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the Judicial Studies Board. The Magistracy has a Bench
Book specifically concentrating upon equal treatment
which has some details of ADHD, but it is not known
how widely this is utilized within the courts. Specific
training in mental health is not provided for Magistrates
but it is available for Crown Court Judges.
Should ADHD be recognised at any stage of the court
process, it could be referred as necessary to health pro-
fessionals and/or the Probation Service to assist the court
in its sentencing decisions. The National Probation Ser-
vice provides pre-sentence reports to assist the judiciary
with sentencing decisions. Some reports are described as
‘Standard Delivery’ taking up to three weeks (i.e. invol-
ving more serious offending and/or complexity of offen-
der needs) and others are ‘Fast Delivery’ taking up to five
days. Considerations necessitating the request of psychia-
tric reports arise from Section 157 of the Criminal Justice
Act 2003 which places an obligation upon the court to
consider a medical report in “any case where the offender
is or appears to be mentally disordered” (s157 (1)) “unless
the court is of the opinion it is unnecessary” (s157 (2)).
Section 207 of the same Act also requires evidence of a
registered medical practitioner if a mental health treat-
ment requirement as part of a community order is
required. Currently some court areas are developing ser-
vice level agreements for the provision of such reports as
suggested within the Bradley Report [19].
There is a Government expectation that the propor-
tion of Fast Delivery Reports will increase to 70%, there-
fore ADHD screening needs to be built into initial
screening processes (which vary across probation areas)
in order to flag up whether the greater level of assess-
ment provided by a Standard Delivery Report is
required. With this in mind, probation staff would need
training to screen for ADHD and learn how and from
where to access diagnosis and treatment. The most
likely procedure would be referral to a forensic psychia-
tric service for a comprehensive assessment. An area for
development is for Local Criminal Justice Boards to
establish effective protocols with health service providers
to ensure that there are cost effective and practical
arrangements for diversion and treatment for Court
users with mental health problems and/or learning
disabilities.
Probation Services
As part of the National Offender Management Service,
the probation service is made up of 42 Probation Trusts
that operate independently from each other to manage
offenders and monitor them through the orders imposed
by the courts (Sentences). Offender Managers provide
interventions, (e.g. Accredited Programmes, Employ-
ment Training and Education and Community Payback)
and monitor their clients’ progress and, while there are
national standards, each Trust and is encouraged to tai-
lor responses to local needs and priorities and the offen-
der profiles within their areas. Joint Needs Assessments
are thus conducted between the National Offender
Management Service and Primary Care Trusts (PCTs)
resulting in targeted Offender Care Pathways that also
reflect national initiatives (this is captured within the
regional Offender Health Delivery Plan). One such
initiative is the provision of mentoring/peer education
services invested in by Probation Trusts and PCTs (e.g.
the emergence of ‘Peer Health Educators’). These initia-
tives are in the early stages of development (relatively
speaking) but have a significant role to play in an offen-
ders’ journey as they provide continual support for the
offender from custody to the community. Thus Peer
Health Educators could develop their knowledge and
skills about ADHD and prompt referrals from Offender
Managers.
A useful tool for the identification of need is the
Offender Assessment System (OASys), which has the
potential to provide further determination of what bar-
riers may exist for an offenders’ ability to adhere to
their rehabilitation requirements. OASys provides an
opportunity for the identification of non-criminogenic
needs with work ongoing to identify how Offender
Managers can be made aware of issues such as ADHD,
thus influencing the care pathway for an individual, and
Table 4 Key recommendations for Court and Probation
Services from the Bradley Report Executive Summary
(2009)
- Information on an individual’s mental health or learning disability
needs should be obtained prior to an Anti-Social Behaviour Order or
Penalty Notice for Disorder being issued, or for the pre-sentence report
if these penalties are breached.
- The Crown Prosecution Service should review the use of conditional
cautions for individuals with mental health problems or learning
disabilities and issue guidance to advise relevant agencies.
- Immediate consideration should be given to extending to vulnerable
defendants the provisions currently available to vulnerable witnesses.
- Courts, health services, the Probation Service and the Crown
Prosecution Service should work together to agree a local service level
agreement for the provision of psychiatric reports and advice to the
courts.
- The judiciary should undertake mental health and learning disability
awareness training.
- Liaison and diversion services should form close links with the
judiciary to ensure that they have adequate information about the
mental health and learning disabilities of defendants, and concerning
local health and learning disability services.
- All probation staff (including those based within courts and approved
premises) should receive mental health and learning disability
awareness training.
- Further work should be undertaken to ensure better implementation
of the Care Programme Approach for people with mental health
problems in prisons, to ensure continuity of treatment through the
prison gate.
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the use of OASys for this purpose could well be in addi-
tion to any local assessment tools that exist.
Whichever stage an offender is at (police, courts,
prison, on licence) a protocol would need to be estab-
lished for the effective identification of which offenders
have ADHD so that this can be taken into account in
terms of assessing offending behaviour (e.g. court
reports, proposals made to sentencers) and ensuring
that the interventions meet offender needs (in order to
maximise their chances of compliance and successful
completion). Any protocol would need to be established
with each Probation Trust, ideally working in partner-
ship with other agencies, including health, thus provid-
ing the best means of ensuring that the needs of
offenders with ADHD are identified, diagnosed and met.
Prison Services
Table 5 presents key recommendations for the prison
service from the Bradley Report Executive Summary
[19]. In most areas PCTs are responsible for contracting
for prison health care at a primary level (i.e. GPs pro-
vide primary medical input and go into prisons on a ses-
sional basis) and at a secondary level (usually provided
by an adjacent Trust). Thus commissioners could
request that ADHD screening, assessments and inter-
ventions are included under this care contract. There
are several opportunities within the prison care system
through which ADHD could be identified:
1) Primary care health workers.
2) Mental health in-reach teams.
3) General forensic psychiatrists.
4) GPs.
5) Specialist learning disability nurses.
More informally, wing staff are the ‘eyes and ears’ of
the prison. They interact with inmates on an intensive,
daily basis and, whilst they usually lack the ability to
describe perceived difficulties in medical terms, they are
well placed to identify when a prisoner is ‘different’ or
unwell.
Prison reception health screens are currently being
reviewed. The current procedure (the ‘Grubin’ screen) is
a two-part procedure comprising a brief screen for
depression and suicidal ideation followed by a more
comprehensive health screen to which ADHD items
could be added. Currently around half of individuals
entering the prison system complete both sections.
While ADHD could be incorporated into this screen, it
is important to maintain the brevity of the screen.
Furthermore, several needs will compete with ADHD
for inclusion (e.g. autism, learning disability, physical ill-
ness etc), however given the high rate of ADHD among
prisoners involved in institutional critical incidents, we
need to lobby for ADHD to be prioritised. A substantial
barrier to the identification of ADHD and the delivery
of mental health care in prison is the high turnover of
inmates. The prison population nears 90,000 with
around 200,000 new names introduced each year, and
over 50% of prisoners serve less than six months before
moving on to community supervision. In addition, the
frequency of inter-prison transfers means that data-shar-
ing protocols across authorities will be essential.
Forensic Mental Health Services
Rates of ADHD are disproportionately high in personal-
ity disorder wards in forensic mental health services
(early data from an ongoing study at the high-secure
Broadmoor Hospital indicate a prevalence of 25%), and
addiction populations (20%) [25]. The persistence of
ADHD symptoms has been associated with elevated
rates of critical incidents (specifically verbal aggression
and damage to property) within personality disordered
patients detained under the Mental Health Act [17], and
with the average length of stay in medium security
being two to four years (and costing c.£170,000 per
year) there is ample opportunity for a comprehensive
screening and diagnostic programme to be introduced.
Within mental health services there is an existing
infrastructure into which ADHD awareness will fit. In
order to successfully build on this framework, two
important factors were identified:
1) The development and provision of accessible infor-
mation and resources for staff and patients and their
families.
2) The development and provision of a monitoring
checklist to record assessment and prescription informa-
tion for the patient, which can be completed by multi-
disciplinary staff.
However, whilst routine screening is conducted on
admission to forensic inpatient services, this is not routi-
nely conducted in community services where the major-
ity of ADHD offenders with mental disorder are likely
to be found. Existing screening procedures, where pro-
vided, are unlikely to include ADHD, and in some cases
Table 5 Key recommendations for the prison service from
the Bradley Report Executive Summary (2009)
- A study should be commissioned to consider the relationship
between imprisonment for public protection sentences and mental
health or learning disability issues.
- An evaluation of the current prison health screen should be
undertaken in order to improve the identification of mental health
problems at reception into prison.
- NHS commissioners should seek to improve the provision of mental
health primary care services in prison.
- Prison mental health teams must link with liaison and diversion
services to ensure that planning for continuity of care is in place prior
to a prisoner’s release, under the Care Programme Approach.
- Awareness training on mental health and learning disabilities must be
made available for all prison officers.
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ADHD may be misdiagnosed (e.g. as personality disor-
der), thus emphasising the importance of training for
professionals in ADHD assessment and diagnosis, which
does not currently feature in generic training curricula.
Interventions for ADHD
The conclusion of NICE guidelines for the treatment
and clinical management of adults with ADHD [1] was
that ADHD needed to be screened for and recognised,
following which a referral to an expert in the diagnosis
and treatment of ADHD should be made. The recom-
mended first line treatment for adults with ADHD is
methylphenidate, followed by second line treatments
with either atomoxetine or dexamphetamine. In high
risk populations consideration should be given to the
use of atomoxetine as the first line choice, where abuse
and/or diversion of stimulant medication are considered
potential risks. Drug treatments for ADHD should
always be considered as part of a comprehensive treat-
ment programme addressing psychological, behavioural
and educational or occupational needs.
The treatment of ADHD in the prison population is
expected to have three main benefits. First, the reduc-
tion of symptoms of ADHD that impact adversely on
behaviour within the prison setting, such as inattentive-
ness, physical restlessness, impulsive responding and
mood instability. Second, the reduction of ADHD symp-
toms will enable individuals within the prison system to
take better advantage of rehabilitation programs aimed
at the reduction of recidivism and improved behavioural
control. Third, the treatment of underlying ADHD may
lead to improvements in comorbid disorders such as
antisocial and borderline personality disorders, sub-
stance abuse disorders including addiction, and anxiety
and depression including the risk for suicide.
We can therefore see that treatment of ADHD within
offender populations fits well with the Risk-Needs-
Responsivity principle, which proposes that treatment is
targeted at the riskiest cases and at needs relevant to the
service (e.g. treatment targeting criminogenic needs in
offending populations). Programmes that adhere to the
Risk-Needs-Responsivity principle, with strong strategies
for reducing criminality, have been shown to be particu-
larly effective in rehabilitating offenders and reducing reci-
divism [26]. Working within this model, there are three
broad aspects that relate to treatment for ADHD offenders:
1) Pharmacological treatments to alleviate ADHD
symptoms.
2) Psychological treatments aimed at improving strate-
gies for self-control and reduction of antisocial attitudes
and behaviours.
3) Concurrent treatment of comorbid disorders.
Offenders with untreated ADHD can be particularly
difficult to manage in prison/institutional environments.
Individuals with high levels of ADHD symptoms were
recently found to have an 8-fold greater number of criti-
cal incidents in a Scottish prison and a 6-fold greater
number of critical incidents than inmates with Antiso-
cial Personality Disorder [15]; mainly consisting of ver-
bal and physical aggression. Critical incidents of this
type have also been found in personality disordered
patients screening positive for ADHD and who are
detained under the Mental Health Act [17]. The Young
study [15] further found that the increased rate of criti-
cal incidents among prison inmates with ADHD could
not be accounted for solely by co-occurring behavioural
disorders, since the association with ADHD remained
significant after controlling for Antisocial Personality
Disorder. This suggests that there is something about
ADHD itself that leads directly to an increased rate of
critical incidents with prison/institutional settings, and
these behavioural problems might therefore be expected
to respond to treatments that reduce levels of ADHD
symptoms.
The reasons for the particularly high rates of beha-
vioural disturbance with prison inmates with ADHD are
likely to stem from several sources related to the core
syndrome of ADHD, including impulsive responding,
mood instability, emotional dysregulation and low frus-
tration tolerance [27-30]. Gudjonsson and colleagues
[31] also found that prison inmates with ADHD have a
particularly chaotic or disorganised style of behaviour
that may also contribute to their behavioural problems.
However, we also know that ADHD is associated with
the development of conduct disorder during childhood
and adolescence and this may lead to antisocial beha-
viours in adulthood. ADHD is therefore an important
risk factor for the development of later antisocial beha-
viour. Left untreated, ADHD is likely to be an exacer-
bating factor that maintains antisocial behaviour and
reduces the ability of an individual to alter their beha-
vioural patterns.
Clearly ADHD has a greater impact on people than just
the core symptoms of the disorder. In most cases the dis-
order starts during early childhood and has a negative
impact in many areas of life throughout the lifespan
[reviewed in 1]. One view of ADHD, supported by avail-
able data, is that children with ADHD are particularly
susceptible to risk factors for the development of beha-
vioural disorders, such as background social environment
and genetic factors, and the often adverse negative events
resulting from ADHD such as poor social interactions,
poor engagement with education and exclusion from
mainstream activities. Thus treatment within criminal
justice settings will usually require the integration of
interventions for comorbid mental illness, personality
disorder, substance misuse, psychological problems, edu-
cational and occupational needs, criminogenic and other
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offence related factors. Treatment of ADHD is expected
to enhance the effectiveness of these important interven-
tions by reducing key symptoms and behaviours that act
as a barrier to recovery and rehabilitation; including
greater control over emotional and impulsive responses,
reduced levels of restlessness, increased ability to focus
and plan ahead and improved ability to take part in psy-
chological treatment programs.
Pharmacological treatments for ADHD
The use of pharmacological treatments for ADHD in
children is well established in the UK and across Eur-
ope, with approximately 1% of the child population
receiving stimulants or atomoxetine for ADHD [32].
The pharmacological treatment of adults with ADHD is
similar to that in children, since drug treatment trials
have been found to be equally effective in adults as chil-
dren [33]. Overall the effectiveness of stimulants or ato-
moxetine in adults compares well to other drug
treatments for mental health disorders, such as the use
of antidepressants to treat depression; and for this rea-
son NICE [1] and other recent expert reviews [1,34]
conclude that drug treatments for ADHD in adults are
the first line choice when considering treatment options.
This is particularly true when treating people with
ADHD with severe levels of impairment and/or asso-
ciated behavioural problems, when implementing rapid
and effective treatments is thought be most important
[1]. In adults there is as yet insufficient evidence to
recommend psychological approaches as first line treat-
ments, although this might be suitable in less severe
cases. It is however important to pay attention to the
NICE recommendation that drug treatments for ADHD
should always be considered as part of a comprehensive
treatment programme addressing psychological, beha-
vioural and educational or occupational needs.
The recommended first line treatment for ADHD in
adults is methylphenidate, followed by dexamphetamine
or atomoxetine. Currently none of the drugs available to
treat ADHD in the UK are licensed for use in adults,
although treatment trials required by the regulatory
bodies are underway that are expected to lead to exten-
sion of current licensing to the adult population. Ato-
moxetine is licensed for use in adults but only as a
continuation of treatment first initiated during child-
hood or adolescence (before the age of 18 years). This
situation is an anomaly because in many cases pharma-
cological treatments are licensed for use in adults but
not paediatric populations and the risks associated with
stimulants are not thought to be greater in adults. Parti-
cular concerns in adults include cardiovascular changes
such as increased pulse and blood pressure that need to
be carefully monitored, although this is similar to many
other drugs used in adults. Despite these potential
problems, having fully reviewed available evidence, UK
national guidelines from NICE [1] recommend that in
most cases pharmacological treatments are used once
the diagnosis of ADHD has been made in adults.
The main treatment effects recorded in drug treatment
trials are improvements in levels of inattention, hyperac-
tive and impulsive behaviours and symptoms. Studies
have also documented a wider range of improvements on
social and academic function and an individual’s overall
sense of well-being. Some studies have specifically
reported on reductions in aggressive behaviour, with
stimulant effect sizes being similar to those reported for
core ADHD symptoms [35]. An important series of stu-
dies investigated mood symptoms in addition to core
ADHD symptoms and found similar effect sizes for both
sets of symptoms when treating adults with ADHD with
either stimulants or atomoxetine [27,28]. For example, in
one study of methylphenidate it was found that there was
a correlation in the improvement of mood symptoms
with ADHD symptoms during the treatment process of
around 0.8 [28].
The nature of the symptoms that improve with stimu-
lant medication can best be understood from the
descriptions given by patients being treated for ADHD
[36]. The rapid onset and marked impact of stimulants
on ADHD symptoms is widely reported by people with
ADHD taking such treatments. Typically people say that
within a short time of taking the medication they feel
calmer, more focused and better able to initiate and
complete tasks. They report improvements in their abil-
ity to focus their attention, greater motivation and
reward from usual activities of daily life, improved abil-
ity to plan ahead with less forgetfulness and increased
levels of self-organisation. Impulsive symptoms are
reduced with less subjective and objective restlessness.
Problems such as mood swings greatly reduce and they
find that situations in which they were particularly
prone to become irritable or aggressive, such as waiting
turn in queues or being irritated by other peoples
responses, are now far more easy to manage. Overall
there is greater control over behaviour and people may
find they can stop and think more easily, rather than
acting in a more impulsive and unthinking way. Subjec-
tively people find that their mind is much calmer, more
relaxed and they are better able to focus their thoughts.
This is often described as part of an overall reduction in
both mental and physical overactivity. People with
ADHD typically describe their mind as always on the
go, a kind of ceaseless mental activity with multiple
short lived or flitting thoughts going on at the same
time. This kind of excessive and unfocused internal
mental activity is often associated by people with the
tendency to talk over or interrupt people or their diffi-
culty in attending to what people are saying to them,
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including following simple instructions. Overall people
treated for ADHD report numerous changes in their
mental state and behaviour which can be best charac-
terised as improved self-control over core processes
such as attention, impulsive responding and emotional
control.
Delivery of drug treatments within the prison setting and
abuse potential
Prescribing stimulant medication in CJS settings may
be perceived as unattractive due to the drug being
(currently) off-licence, the controlled drug status for
stimulants and abuse potential. The potential for abuse
was recognised by NICE who suggest that atomoxetine
may be a better option where this is a particular
concern because it is not a controlled drug and is a
non-stimulant. However the overall effectiveness of sti-
mulants, which NICE consider to be greater than ato-
moxetine, means that stimulants should also be
considered either as a first line or second line choice.
The delivery of medication within the prison setting
should not however be a problem, since many prisons
already run medication-based programmes for con-
trolled drugs (e.g. methadone maintenance) and suc-
cessfully adhere to protocols and policies that aim to
reduce the chances of mismanagement.
The abuse potential for stimulants is however often
overstated and usually by professionals who are not
familiar with the effects of stimulants in the treatment
of ADHD. First, we know from follow-up studies that
the use of prescribed stimulants is not associated with
an overall increase in drug abuse problems and may be
associated with a reduction in illicit drug use [37-39].
Second, one of the main problems in treating children
with ADHD as they grow older is keeping them on sti-
mulant medication, even when this thought to be
important to their continued mental health. This is
because many adolescents no longer wish to engage in
the treatment program and prefer to stop medication,
even when it is perceived by others (parents, teacher or
professionals) to be beneficial. There is therefore no
indication that stimulants are addictive when prescribed
for the treatment of ADHD. Third, studies in the US
where stimulants are more widely prescribed point
towards the main misuse of stimulants being diversion
to increase performance at work or in education, how-
ever the rates of stimulant prescriptions in the US is far
higher than in the UK to high functioning individuals
where academic performance is the main concern. Over-
all the potential benefits of treatment, particularly in
highly impaired individuals, appear to greatly outweigh
the potential risks. Risk assessments should however be
carried out in each individual case and consideration
given to the particular drug formulations prescribed.
Drugs with low abuse potential include atomoxetine
which is a non-stimulant and long acting formulation,
those where the stimulant cannot be easily extracted for
injection, such as methylphenidate OROS in the UK or
skin patches and long acting lisdexamphetamine in the
USA.
Psychological treatments for ADHD
NICE recommends that drug treatment should always
form part of a comprehensive treatment plan that
includes psychological, behavioural and educational
advice and interventions. Medication is likely to improve
adherence to psychological treatments such as offender
treatment programmes and other therapeutic, educa-
tional and occupational activities. Thus addressing
ADHD may have a two-fold impact in crime reduction,
first by directly treating the disorder (e.g. reducing
symptoms) and secondly by improving engagement with
rehabilitative programmes. Specific programmes have
been developed that integrate the two, and there is
some evidence from studies in children that psychologi-
cal therapies, in combination with drug treatments lead
to greater sustained effects and greater effects on
comorbidity [40]. However, although recent research
supports the use of cognitive behavioural methods for
treating adult ADHD [41-43], treatment with psycholo-
gical therapy remains an under-researched area and a
priority for future research. Psychological and psycho-
educational programmes are available that provide
advice on how to adapt treatments to suit those with
ADHD [e.g. 44, 45]. The R&R2 ADHD offender pro-
gramme [45] for example, is currently being evaluated
in a randomised controlled trial (RCT) in Iceland. Preli-
minary results from a community pilot study of R&R2
has shown it to be effective in treating ADHD adults
with comorbid difficulties, with the effect continuing to
improve at three-month follow-up [46].
The commissioning of treatment
Providing access to regular treatments of the right kind
is generally a commissioning matter, however the evi-
dence base needs to be expanded to evaluate newly
developed, specialist programmes. A useful starting
point might be to simply promote awareness of ADHD
among those facilitating treatments.
Treatment protocols in prison are supported by PCT
commissioning through links to care standards in the
wider community, and it may be beneficial to take a
phased approach. It may be sensible to target those with
longer sentences, maximising opportunity for initiation
and optimisation of treatment. Identification and treat-
ment of ADHD inmates is likely to reduce behavioural
disturbance within the prison setting but additionally
improve engagement with therapeutic, education and
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occupational activities. Education is provided on a smal-
ler scale in prison than in the community (e.g. two or
three to a class) and one-to-one attention will optimise
motivation, co-operation and learning. Greater under-
standing about ADHD and associated problems will
maximise treatment benefit and increase the chance of
successful rehabilitation and constructive skills
acquisition.
The NHS is now responsible for the delivery of prison
healthcare, however in the past practitioners in forensic
mental health services have lacked confidence in pre-
scribing stimulants, perhaps due to a lack of clinical
guidelines. Thus, treatment plans need to be multidisci-
plinary and comprehensive, and need to recommend sti-
mulant/drug therapy as a precursor to psychological
work addressing criminogenic factors.
In the short-term, outcome needs to be assessed using
symptom screens and staff measures to assess beha-
vioural improvement (e.g. in treatment engagement,
reduction in institutional disturbance). Longer-term
effects may include transfer to a lower (and therefore
less costly) level of security with greater opportunity to
access rehabilitation, and reduction in antisocial and
criminal behaviour.
In the community, after discharge from prison, some
individuals will have contact with probation staff and/or
be subject to a Multi Agency Public Protection Arrange-
ments (MAPPA) review. This service provides psychoso-
cial support for prisoners in the community, thus
effective links with local mental health services and sup-
port agencies, and information sharing is necessary.
The Need for Integrated Pathways
A common theme that arose during the meeting was
the need for integrated care pathways between CJS
agencies. Excellent service provision in one setting is of
little benefit without continued care through integrated
pathways. For persistent offenders, the pathway is not
linear but often cyclical as they may move through
stages multiple times (see Figure 1). It is crucial that
continuity between services parallels the individual’s
progression though the system. Inevitably this will
require effective IT systems and a new generation of
systems will be delivered in 2010 providing improved
links both between prisons and community care.
It was recognised that it is important to establish a con-
tinuous, integrated care pathway that follows the offender
‘journey’ from initial police contact through to eventual
resettlement, and that interfaces health with the CJS ser-
vices. This may include a criminal justice liaison to
address factors that may impede justice or consider cus-
todial alternatives for some individuals (e.g. community
orders, treatment services). The contribution of mental
health staff at court will improve identification of mental
health issues, including ADHD. It will be important to
develop joint (or comparable) risk and health assess-
ments across CJS partners, and provide training and
common information sharing protocols and management
systems. Referral pathways post-identification must be
effective with RCT research a priority, as a strong health
economic case must be established.
The core NHS care within the CJS is provided by pri-
mary care services (GPs) and secondary psychiatric ser-
vices, and the key to an integrated pathway for many
offenders will be the transfer of care, especially for those
leaving prison (e.g. via their GP). The GP is the gate-
keeper for referrals to community services. For those
offenders without a GP, PCTs aim to implement
straightforward procedures to facilitate GP registration
(some may not have been successful in the past due to
communication barriers, inability to complete paper-
work, etc). This process will be assisted by the probation
service who are involved with offenders from before
they leave prison in order to assess risk, and continue to
mentor them in the community. This includes a multi-
agency Reducing Reoffending Delivery Plan, which aims
to reduce reoffending and ensures that all offenders
have a GP. However, probation staff do not work with
everybody leaving prison and those with short-term cus-
tody tariffs are unlikely to receive a probation service
at all.
Awareness about ADHD and its implications (e.g. in
different settings) throughout the whole care pathway
will be essential in supporting ADHD offenders to reha-
bilitate into the community and make lasting change.
This involves ensuring that services exist within the
community to support offenders with ADHD in bring-
ing about continuity of care. Gaining support from a
keyworker or mentor will assist ADHD offenders to
access continued care. The provision of psychoeduca-
tional materials about ADHD for voluntary sector com-
munity agencies and charities will assist them in their
endeavours to support ADHD offenders in linking with
healthcare, re-housing, and management of finances and
employment.
However, we are in a climate of strong competition
for resources; some individuals may require a lot of
home supervision in the community, frequent medica-
tion monitoring/delivery and occupational support may
also be required. One factor that will impact on service
provision will be a move towards ‘payment by results’,
which involves the clustering of detainees to correlate
improvement over time with outcome measures. These
clusters are likely to represent major sources of concern,
such as schizophrenia. Adult ADHD patients may
require the same amount of resources as severely psy-
chotic patients but respond to treatment more quickly
and effectively. This emphasises the need to develop an
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evidence base for the treatment of ADHD offenders and,
critically, to include health economic modelling when
evaluating outcome.
Conclusions
The aim of putting health and social care at the heart of
the CJS has governmental support. However, it is impor-
tant that health and criminal justice agencies work
together to find ‘win-win’ solutions for managing indivi-
duals and their care, in turn providing better justice,
more efficient services and better health and social out-
comes. At present, ADHD is not on the agenda, and
bringing together key experts in the field proved diffi-
cult, with most being either experts in adult ADHD or
experts within the CJS. This illustrates well the chal-
lenge that lies before us in raising awareness of adult
ADHD within the CJS. Given the disproportionately
high rates of ADHD offenders compared with the nor-
mal population and the association with violent, persis-
tent offending, ADHD is a condition that the CJS
cannot afford to ignore.
Training and work force development will be impor-
tant to improve awareness and basic understanding of
ADHD in order to signpost appropriate healthcare and
rehabilitation. This needs to be introduced at every
stage of the offender pathway to maximise the support
that can be offered and the success of rehabilitation.
Table 6 summarises key conclusions for screening, treat-
ment, training, commissioning of ADHD forensic ser-
vices and key areas of research. Whilst this consensus
draws on the UK experience, with some adaptations it
can be used as a template for similar local actions in
other countries. Brief ADHD screening tools (with
appropriate sensitivity and specificity) need to be intro-
duced in all the criminal justice services as currently
there is no such provision. Screening will alert a poten-
tial need and trigger a second stage process (e.g. diag-
nostic assessment, AA safeguard, an extension on Fast
Delivery Reports to allow time for a more comprehen-
sive probation report).
Having identified ADHD in an offender, appropriate
support needs to be made available and the develop-
ment of shared communication across disciplines/ser-
vices via IT services will provide opportunities to help
individuals who otherwise go without. GPs appear to be
ideally placed for early identification and intervention,
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but variability in services due to the broad and complex
range of individuals seen in primary care, and the differ-
ent pathways through which individuals enter the CJS
means this cannot be the only provision relied upon.
Continuity of care is critical both through and after the
CJS, with patient education and system training essen-
tial. It is important to bear in mind that, while there is a
need for shared responsibility in terms of understanding
and evaluating adult ADHD, services within the CJS are
not surrogate health and educational services. Provisions
need to be made in the community, in police stations,
and in the transition from other services, to maximise
the opportunity for identification, intervention and
prevention.
A comprehensive research programme will be
required to expand existing ADHD evidence into the
realm of the CJS involving joint working and commis-
sioning. In particular, proof of principle studies are
needed to demonstrate effectiveness in health, behaviour
and offence-related outcomes (including crime reduc-
tion). There are effective interventions for ADHD at any
age, however a separate but related strategy for youth
offenders will offer a preventative focus by providing
crucial opportunities for treatment and support. It will
be essential to include health economic modelling to
demonstrate the service consumption costs of ‘doing
nothing’ compared with the financial benefit of interven-
tion and, potentially, prevention.
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Table 6 Summary of key conclusions
Screening and Assessment
- Screening tools are needed in police custody suites, courts, prison and
probation services; while screening procedures exist across CJS services
with a range of sensitivities and specificities, these exclude ADHD.
- ADHD screening tools exist for this purpose (e.g. the Barkley
ADHD scales [47] and the Adult ADHD Self-Report Scale [48]
however initial screens may need to be briefer.
- For diagnosis, of particular importance is the issue of comorbidity,
which can complicate symptom presentation and hinder
identification of adult ADHD. Differentiating between diagnoses (e.
g. between ADHD and personality disorder) requires distinct,
evidence-based diagnostic tools with ADHD criteria specific to
adulthood.
- Advice is available [49] and, as recognised by NICE, it will be
necessary to include ADHD alongside other mental health
conditions that currently have much greater awareness/training.
Treatment
- ADHD can be effectively treated by a range of therapies
providing many opportunities and benefits of treatment across the
CJS.
- Psychosocial interventions have been specifically designed for this
(e.g. adapted R&R2 [45]).
- It may not be easy to encourage service managers and policy-
makers to embrace new developments into care pathways and
crime reduction strategies, but systems must be put in place for
those with health needs who remain in prison care.
- Evidence for ADHD treatment is needed and must link with
health economic modelling.
Training
- Little is known about the operational challenges of ADHD for
prison staff and how these might be addressed.
- Greater understanding and awareness is key for improving
assessment, diagnosis and treatment of adult ADHD, and continuity
of care. This will require training across the CJS.
- Training in ADHD for medical staff is minimal, and needs to be
increased.
- Training must extend beyond the medical discipline to all CJS
agencies.
Commissioning
- PCT commissioning is the way forward in developing and
modifying services, and a key issue in this regard is evidence.
- Establishing links between treatment and outcome is crucial (e.g.
the direct correlation between methadone maintenance and
reducing offending has demonstrated that detoxification
programmes reduce both drug use and offending thus solving two
problems).
- Both health and CJS commissioners will be attuned to
interventions with the strongest evidence base. For ADHD this will
require evidence of health and offence-related outcomes.
- Service provision is additionally determined by value for money,
which further emphasises the need to demonstrate an economic
argument for change within services.
Key areas of research
- Educational needs assessment across the CJS to determine
knowledge, skills, attitudes and values, and identify training needs.
- Proof of principle studies to evaluate the use of screening
measures across the CJS
- Proof of principle studies to evaluate treatment efficacy; using
health and offence-related outcomes
- Cost-effectiveness studies using health economic modelling
techniques to strengthen the case for ADHD treatment (e.g. each
person prevented from entering prison saves £75,000p.a).
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